Calvin Yee

Person

Nutley, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Cycloalkyl pyrimidines as ferroportin inhibitors
- Patent number 12,202,817
- Issue date Jan 21, 2025
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cycloalkyl pyrimidines as ferroportin inhibitors
- Patent number 11,746,100
- Issue date Sep 5, 2023
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds as histone methyltransferase inhibitors
- Patent number 11,584,734
- Issue date Feb 21, 2023
- Global Blood Therapeutics, Inc.
- Ming Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 11,530,191
- Issue date Dec 20, 2022
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ferroportin inhibitors and methods of use
- Patent number 11,286,243
- Issue date Mar 29, 2022
- Global Blood Therapeutics, Inc.
- Zhe Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 11,236,109
- Issue date Feb 1, 2022
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 10,829,470
- Issue date Nov 10, 2020
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 10,266,551
- Issue date Apr 23, 2019
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bridged bicyclic kallikrein inhibitors
- Patent number 10,144,746
- Issue date Dec 4, 2018
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 10,100,040
- Issue date Oct 16, 2018
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 9,981,939
- Issue date May 29, 2018
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bridged bicyclic kallikrein inhibitors
- Patent number 9,815,853
- Issue date Nov 14, 2017
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyridine pyrazolopyrimidine and related compounds
- Patent number 9,695,166
- Issue date Jul 4, 2017
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrazine kinase inhibitors
- Patent number 8,329,699
- Issue date Dec 11, 2012
- Hoffmann-La Roche Inc.
- Robert Than Hendricks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrazine kinase inhibitors
- Patent number 7,939,531
- Issue date May 10, 2011
- Roche Palo Alto
- Joe Timothy Bamberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrazine kinase inhibitors
- Patent number 7,932,254
- Issue date Apr 26, 2011
- Roche Palo Alto
- Daisy Joe DuBois
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS
- Publication number 20240140932
- Publication date May 2, 2024
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20230322704
- Publication date Oct 12, 2023
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS
- Publication number 20230226074
- Publication date Jul 20, 2023
- Global Blood Therapeutics, Inc.
- Qing Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20220402940
- Publication date Dec 22, 2022
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS
- Publication number 20220396562
- Publication date Dec 15, 2022
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20220119407
- Publication date Apr 21, 2022
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20210261520
- Publication date Aug 26, 2021
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS
- Publication number 20200361896
- Publication date Nov 19, 2020
- Global Blood Therapeutics, Inc.
- Ming YU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FERROPORTIN INHIBITORS AND METHODS OF USE
- Publication number 20200190045
- Publication date Jun 18, 2020
- Global Blood Therapeutics, Inc.
- ZHE LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20200048280
- Publication date Feb 13, 2020
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20190112287
- Publication date Apr 18, 2019
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRIDGED BICYCLIC KALLIKREIN INHIBITORS
- Publication number 20180194780
- Publication date Jul 12, 2018
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20180186807
- Publication date Jul 5, 2018
- Global Blood Therapeutics, Inc.
- Calvin W. YEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRIDGED BICYCLIC KALLIKREIN INHIBITORS
- Publication number 20160362427
- Publication date Dec 15, 2016
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20160046613
- Publication date Feb 18, 2016
- Global Blood Therapeutics, Inc.
- Brian W. METCALF
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20160031865
- Publication date Feb 4, 2016
- Global Blood Therapeutics, Inc.
- Zhe LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20160031904
- Publication date Feb 4, 2016
- Global Blood Therapeutics, Inc.
- Zhe LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLOPYRIDINE PYRAZOLOPYRIMIDINE AND RELATED COMPOUNDS
- Publication number 20150315198
- Publication date Nov 5, 2015
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20150141465
- Publication date May 21, 2015
- Global Blood Therapeutics, Inc.
- Calvin W. YEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLOPYRAZINE KINASE INHIBITORS
- Publication number 20140155376
- Publication date Jun 5, 2014
- Hoffmann-La Roche Inc.
- Robert Than Hendricks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrrolopyrazine Kinase Inhibitors
- Publication number 20110288067
- Publication date Nov 24, 2011
- Robert Than Hendricks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrrolopyrazine Kinase Inhibitors
- Publication number 20110288097
- Publication date Nov 24, 2011
- Robert Than Hendricks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrrolopyrazine kinase inhibitors
- Publication number 20090215750
- Publication date Aug 27, 2009
- Joe Timothy Bamberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrrolopyrazine kinase inhibitors
- Publication number 20090215724
- Publication date Aug 27, 2009
- Daisy Joe DuBois
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Cycloalkyl pyrimidines as ferroportin inhibitors

Cycloalkyl pyrimidines as ferroportin inhibitors

Tricyclic compounds as histone methyltransferase inhibitors

Compounds and uses thereof for the modulation of hemoglobin

Ferroportin inhibitors and methods of use

Compounds and uses thereof for the modulation of hemoglobin

Compounds and uses thereof for the modulation of hemoglobin

Compounds and uses thereof for the modulation of hemoglobin

Bridged bicyclic kallikrein inhibitors

Compounds and uses thereof for the modulation of hemoglobin

Compounds and uses thereof for the modulation of hemoglobin

Bridged bicyclic kallikrein inhibitors

Pyrazolopyridine pyrazolopyrimidine and related compounds

Pyrrolopyrazine kinase inhibitors

Pyrrolopyrazine kinase inhibitors

Pyrrolopyrazine kinase inhibitors

Patents Applicationslast 30 patents

CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS

FERROPORTIN INHIBITORS AND METHODS OF USE

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

BRIDGED BICYCLIC KALLIKREIN INHIBITORS

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

BRIDGED BICYCLIC KALLIKREIN INHIBITORS

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

PYRAZOLOPYRIDINE PYRAZOLOPYRIMIDINE AND RELATED COMPOUNDS

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

PYRROLOPYRAZINE KINASE INHIBITORS

Pyrrolopyrazine Kinase Inhibitors

Pyrrolopyrazine Kinase Inhibitors

Pyrrolopyrazine kinase inhibitors

Pyrrolopyrazine kinase inhibitors